| parent | cefTAZidime+Clavulanate | LP33353-1 |
| child | cefTAZidime+Clavulanate [Susceptibility] | 35776-4 |
| child | cefTAZidime+Clavulanate [Susceptibility] by Disk diffusion (KB) | 35774-9 |
| child | cefTAZidime+Clavulanate [Susceptibility] by Gradient strip | 42352-5 |
| child | cefTAZidime+Clavulanate [Susceptibility] by Minimum inhibitory concentration (MIC) | 35775-6 |
| parent | cefTAZidime+Clavulanate | LP33353-1 |
| child | cefTAZidime+Clavulanate [Susceptibility] | 35776-4 |
| child | cefTAZidime+Clavulanate [Susceptibility] by Disk diffusion (KB) | 35774-9 |
| child | cefTAZidime+Clavulanate [Susceptibility] by Gradient strip | 42352-5 |
| child | cefTAZidime+Clavulanate [Susceptibility] by Minimum inhibitory concentration (MIC) | 35775-6 |
| PartDisplayName | en-US | cefTAZidime+Clavulanate | Isolate | Antibiotic susceptibilities |
LOINC Version: 2.77
FHIR